Human rare disease medicines recommended for marketing authorisation
Number of medicines for human use indicated for the treatment of rare diseases recommended for marketing authorisation.
Unit Count Industry Pharmaceuticals
The chart
The figure
One published observation so far. A chart follows as soon as a second period is published.
Human rare disease medicines recommended for marketing authorisation
European Union, 2025
Every record
All records
1 record · 1 region · 2025
Primary documents
Sources
1 document. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| EMA’s 2025 annual report shows strong approval numbers for human and veterinary medicines | EMA | — | 1 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Human rare disease medicines recommended for marketing authorisation. Retrieved from https://statorigin.org/indicators/human-rare-disease-medicines-recommended-for-marketing-authorisation